Ignite Creation Date:
2024-05-06 @ 7:27 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06013657
Status:
COMPLETED
Last Update Posted:
2023-08-28
First Post:
2023-08-15
Brief Title:
Surgical Resection for Hepatocellular Carcinoma
Sponsor:
Dr Cipto Mangunkusumo General Hospital
Organization:
Dr Cipto Mangunkusumo General Hospital
Study Overview
Official Title:
Surgical Resection for Hepatocellular Carcinoma a Single-Centers One Decade of Experience
Status:
COMPLETED
Status Verified Date:
2023-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Hepatocellular carcinoma is a type of liver cancer and is one of the leading causes of global cancer death Surgical resection of the afflicted areas of the liver is one of the treatment methods for this condition In this retrospective research the investigators explore the outcomes of liver resection for hepatocellular carcinoma patients undergoing liver resection from 2010 to 2021 in Cipto Mangunkusumo General Hospital Jakarta The main outcome is mortality and the secondary outcomes are factors predicting mortality after resection
Detailed Description:
Study design This is a retrospective cohort study
Treatment of Hepatocellular Carcinoma Patients in RSCM HCC patients are managed by a multidisciplinary team MDT consisting of hepatologists radiologists pathologists radiation oncologists surgeons and other specialists related to the patients condition Confirmed HCC patients are discussed in a weekly MDT team meeting The meeting assigned patients to treatment options according to the Barcelona Clinic Liver Center BCLC staging system patient preference and other clinical considerations Resection is considered for patients at very early BCLC 0 or early BCLC A HCC stages This includes CP class A patients with a single tumor or less than three small 3 cm tumors Patients assigned to surgical resection underwent either laparoscopic or open surgery One to four segments of the liver were removed Tissue samples were taken for further pathologic examination
Ethical Clearance The ethics committee of The Faculty of Medicine University of Indonesia approved this study by giving an ethical clearance with protocol number 19-11-1313 Informed consent was taken from all patients
Treatment of Hepatocellular Carcinoma Patients in RSCM HCC patients are managed by a multidisciplinary team MDT consisting of hepatologists radiologists pathologists radiation oncologists surgeons and other specialists related to the patients condition Confirmed HCC patients are discussed in a weekly MDT team meeting The meeting assigned patients to treatment options according to the Barcelona Clinic Liver Center BCLC staging system patient preference and other clinical considerations Resection is considered for patients at very early BCLC 0 or early BCLC A HCC stages This includes CP class A patients with a single tumor or less than three small 3 cm tumors Patients assigned to surgical resection underwent either laparoscopic or open surgery One to four segments of the liver were removed Tissue samples were taken for further pathologic examination
Ethical Clearance The ethics committee of The Faculty of Medicine University of Indonesia approved this study by giving an ethical clearance with protocol number 19-11-1313 Informed consent was taken from all patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None